![Scott Stromatt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott Stromatt
No open positions remaining
Profile
Scott C.
Stromatt worked as a Director of Medical Affairs at G.D.
Searle & Co., Inc. and as a Vice President of Clinical Research at Synergen, Inc. He was also the EVP of Clinical Development & Regulatory Affairs at CTI BioPharma Corp.
and the Chief Medical Officer & VP of Clinical Research at Northwest Biotherapeutics, Inc. He served as the Senior Vice President at C.E.
Unterberg, Towbin Holdings, Inc. and as the Chief Medical Officer & Senior Vice President at Emergent Product Development Seattle and Emergent BioSolutions, Inc. He was also the Chief Medical Officer & SVP of Clinical Development at Aptevo Therapeutics, Inc. Dr. Stromatt earned a doctorate degree from The University of Chicago and an undergraduate degree and an MBA from The University of Colorado.
Former positions of Scott Stromatt
| Companies | Position | End |
|---|---|---|
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical products | Chief Tech/Sci/R&D Officer | 2016-07-31 |
| CTI BIOPHARMA CORP. | Chief Tech/Sci/R&D Officer | 2007-12-31 |
| NORTHWEST BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2003-10-01 |
C. E. Unterberg, Towbin, Inc.
 C. E. Unterberg, Towbin, Inc. Investment Banks/BrokersFinance Provides investment bank services in the technology, healthcare, and security/crime control/anti-terrorism industries | Analyst-Equity | 2002-02-17 |
| APTEVO THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | - |
Training of Scott Stromatt
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
34
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Synergen, Inc.
 Synergen, Inc. Electric UtilitiesUtilities Distributes electricity | Utilities |
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
Northwest Biotherapeutics, Inc.
 Northwest Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes immunotherapy products | Health Technology |
C.E. Unterberg, Towbin Holdings, Inc.
 C.E. Unterberg, Towbin Holdings, Inc. Investment ManagersFinance Provides financial advisory services | Finance |
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical products | Health Technology |
G.D. Searle & Co., Inc.
 G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries Makes diversified line of chemicals and agricultural products | Process Industries |
C. E. Unterberg, Towbin, Inc.
C. E. Unterberg, Towbin, Inc. Investment Banks/BrokersFinance Provides investment bank services in the technology, healthcare, and security/crime control/anti-terrorism industries | Finance |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Colorado
 The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emergent BioSolutions, Inc.
 Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Aptevo Therapeutics, Inc.
 Aptevo Therapeutics, Inc. BiotechnologyHealth Technology Provides immunology and cancer research services | Health Technology |
- Stock Market
- Insiders
- Scott Stromatt
